Online first

Utilizing Machine Learning for Pre- and Postoperative Assessment of Patients Undergoing Resection for BCLC-0, A and B Hepatocellular Carcinoma: Implications for Resection Beyond the BCLC Guidelines

Diamantis I. Tsilimigras MD, Rittal Mehta MPH, Dimitrios Moris MD, PhD, Kota Sahara MD, Fabio Bagante MD, Anghela Z. Paredes MD, MS, Ayesha Farooq MD, Francesca Ratti MD, Hugo P. Marques MD, Silvia Silva MD, Olivier Soubrane MD, Vincent Lam MD, George A. Poultsides MD, Irinel Popescu MD, Razvan Grigorie MD, PhD, Sorin Alexandrescu MD, Guillaume Martel MD, Aklile Workneh MD, Alfredo Guglielmi MD, T
Hepatobiliary Tumors
View abstract | View full article HTML | View full PDF

ASO Author Reflections: Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells in Cholangiocarcinoma Patients

Yuki Kitano MD, PhD, Hideo Baba MD, PhD, FACS
ASO Author Reflections
View abstract | View full article HTML | View full PDF

ASO Author Reflections: Impact of Operative Technique on Anastomotic Failure During Cytoreductive Surgery for Peritoneal Malignancies—Surgeon Preference is Fine

Jason T. Wiseman MD, MSPH, Jordan M. Cloyd MD
ASO Author Reflections
View abstract | View full article HTML | View full PDF

ASO Author Reflections: The Changing Landscape for Industry Support to Surgical Oncologists

Juan A. Santamaria-Barria MD, Anton Bilchik MD, PhD, MBA, FACS
ASO Author Reflections
View abstract | View full article HTML | View full PDF

Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS)

Dario Baratti MD, Shigeki Kusamura PhD, Norfarizan Azmi MD, Marcello Guaglio MD, Matteo Montenovo MD, Marcello Deraco MD
Peritoneal Surface Malignancy
View abstract | View full article HTML | View full PDF

Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia

Bofeng Chen BA, Maxwell T. Trudeau BA, Laura Maggino MD, Brett L. Ecker MD, Luke J. Keele PhD, Ronald P. DeMatteo MD, Jeffrey A. Drebin MD, PhD, Douglas L. Fraker MD, Major K. Lee IV MD, PhD, Robert E. Roses MD, Charles M. Vollmer Jr. MD
Pancreatic Tumors
View abstract | View full article HTML | View full PDF

External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer

Sebastian Brinkmann MD, Bo J. Noordman MD, PhD, Arnulf H. Hölscher MD, PhD, Katharina Biermann MD, PhD, David van Klaveren PhD, Elfriede Bollschweiler MD, PhD, Katharina Pütz MD, PhD, J. Jan B. van Lanschot MD, PhD, Uta Drebber MD, PhD
Thoracic Oncology
View abstract | View full article HTML | View full PDF | Open choice

National Use of Chemotherapy in Initial Management of Stage I Pancreatic Cancer and Failure to Perform Subsequent Resection

Ryan J. Ellis MD, MS, Jessie W. Ho MD, Cary Jo R. Schlick MD, Ryan P. Merkow MD, MS, David J. Bentrem MD, MS, Karl Y. Bilimoria MD, MS, Anthony D. Yang MD, MS
Pancreatic Tumors
View abstract | View full article HTML | View full PDF

Surgical and Surgeon-Related Factors Related to Long-Term Survival in Esophageal Cancer: A Review

Sheraz R. Markar MRCS, PhD, Jesper Lagergren MD, PhD
Thoracic Oncology
View abstract | View full article HTML | View full PDF | Open choice

ASO Author Reflections: How Should the Patients with Locally Advanced Unresectable Esophageal Cancer Be Treated with Multidisciplinary Approach?

Tomoya Yokota MD, PhD, Yuko Kitagawa MD, PhD, FACS
ASO Author Reflections
View abstract | View full article HTML | View full PDF